New University of Florida research identifying an association between glucosamine supplements and accelerated dementia progression has important implications for the millions who use this popular joint pain remedy. The study identified three critical findings: glucosamine supplementation correlates with faster cognitive decline in patients with existing mild cognitive impairment; evidence derived from both clinical records and brain imaging strengthens the reliability of this association; and the widespread use of this supplement means many at-risk individuals may be unknowingly affected.
For patients currently taking glucosamine, particularly those with cognitive concerns or family histories of dementia, consultation with healthcare providers is warranted. While this retrospective analysis cannot definitively establish causation, it highlights the necessity for informed decision-making regarding supplement use. The findings reinforce that over-the-counter status does not guarantee safety for all populations, and personalized medical guidance should inform supplement choices.
Read the full article on GMJ Newsroom.
Was this article helpful?
